Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

Anagrelide reduces thrombotic risk in essential thrombocythaemia vs. hydroxyurea plus aspirin

详细信息查看全文

作者：P&eacute ; ter Dombi ; Á ; rpá ; d Ill&eacute ; s ; Judit Demeter ; Lajos Homor ; Zsofia Simon ; Eva Karadi ; Miklos Udvardy and Miklos Egyed
刊名：European Journal of Haematology
出版年：2017
出版时间：February 2017
年：2017
卷：98
期：2
页码：106-111
全文大小：190K
ISSN：1600-0609

文摘

To evaluate the reduction in thrombotic events (TE) in patients with essential thrombocythaemia (ET) treated with anagrelide versus hydroxyurea + aspirin (HU + ASA).